PAVmed Q2 EPS $(1.19) Beats $(1.45) Estimate, Sales $979.00K Miss $1.20M Estimate
PAVmed Q2 EPS $(1.19) Beats $(1.45) Estimate, Sales $979.00K Miss $1.20M Estimate
pavmed第二季每股收益爲$(1.19)，超過了$(1.45)的預估，銷售額爲$97.9萬，低於$120萬的預估。
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(1.19) per share which beat the analyst consensus estimate of $(1.45) by 17.93 percent. This is a 43.33 percent increase over losses of $(2.10) per share from the same period last year. The company reported quarterly sales of $979.00 thousand which missed the analyst consensus estimate of $1.20 million by 18.42 percent. This is a 489.76 percent increase over sales of $166.00 thousand the same period last year.
pavmed（納斯達克：PAVM）報告每股虧損1.19美元，超出分析師的預估1.45美元，增長了17.93％。這比去年同期每股虧損2.10美元增長了43.33％。該公司報告的季度銷售額爲97.9萬美元，比分析師預估的120萬美元低了18.42％。這比去年同期銷售額16.6萬美元增長了489.76％。